NCT02460900View on ClinicalTrials.gov

Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke

PHASE3CompletedINTERVENTIONAL
Enrollment

184

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
SmokingHIV
Interventions
DRUG

Varenicline

BEHAVIORAL

Positively Smoke Free

DRUG

Placebo

BEHAVIORAL

Standard of Care

Trial Locations (1)

21210

University of Maryland Medical Center, Midtown Campus, Baltimore

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT02460900 - Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke | Biotech Hunter | Biotech Hunter